Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
Support to Prevail 1, 3 & 6
Leidos Biomedical Research, Inc.
7/26/22 → 6/25/23
Project: Research project
-
Pre-Exposure Prophylaxis for Adults of High Risk of Occupational Exposure to Ebola Virus Trial (PREPARE)
Leidos Biomedical Research, Inc.
3/1/22 → 9/25/23
Project: Research project
-
Ebola Master Agreement / 21X184
Leidos Biomedical Research, Inc.
2/1/22 → 1/31/27
Project: Research project
-
Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia
Fallah, M. P., Lane, H. C., Higgs, E. S., Kennedy, S. B., Massaquoi, M. B. F., Kieh, M. W. S., Neaton, J. D., Hensley, L. E., McNay, L., Njoh, W. & Doe-Anderson, J., Mar 2023, In: The Lancet Global Health. 11, 3, p. e321-e323Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study
for the INSIGHT Clostridioides difficile Study Group & Young, J. A. H., Feb 2022, In: Transplant Infectious Disease. 24, 1, e13770.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy
Levi, L. I., Sharma, S., Schleiss, M. R., Furrer, H., Nixon, D. E., Blackstad, M., Hernandez-Alvarado, N., Dwyer, D. E., Borges, A. H., Lane, H. C., Lundgren, J., Neaton, J. D. & Molina, J. M., Jul 15 2022, In: AIDS. 36, 9, p. 1265-1272 8 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K. B., Pett, S., Phillips, A. N., Polizzotto, M. N., & 8 others , Feb 2022, In: Clinical Trials. 19, 1, p. 52-61 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Sep 15 2022, In: American journal of respiratory and critical care medicine. 206, 6, p. 730-739 10 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Press/Media
-
Eli Lilly's antibody trial is paused over potential safety concerns
10/14/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
University of Minnesota leads recruitment to new COVID-19 antibody trial
10/14/20
1 item of Media coverage
Press/Media: Expert Comment or Interview